Mmp9 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Mmp9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The MMP9 gene (Matrix Metallopeptidase 9) encodes gelatinase B, a zinc-dependent protease that degrades extracellular matrix proteins. MMP9 is involved in neuroinflammation and blood-brain barrier disruption in neurodegenerative diseases.
| Attribute | Value |
|---|---|
| Gene Symbol | MMP9 |
| Full Name | Matrix Metallopeptidase 9 |
| Chromosomal Location | 20q13.12 |
| NCBI Gene ID | 4313 |
| OMIM | 120361 |
| Ensembl ID | ENSG00000100985 |
| UniProt ID | P14780 |
MMP9 (gelatinase B) is a key matrix metalloproteinase:
MMP9 is expressed in:
MMP9 (Matrix Metalloproteinase-9, also known as gelatinase B) is expressed in various cell types in the central nervous system:
MMP9 expression is induced by pro-inflammatory cytokines (TNF-α, IL-1β), growth factors, and neuronal activity. The enzyme is stored in granules and released upon cellular activation.
MMP9 is a challenging therapeutic target due to its dual roles in normal physiology and disease:
| Approach | Status | Description |
|---|---|---|
| Broad-spectrum MMP inhibitors | Discontinued | Failed due to side effects |
| Selective MMP9 inhibitors | Research | SB-3CT and derivatives |
| Antibody therapy | Preclinical | Monoclonal antibodies against MMP9 |
| Natural inhibitors | Research | Tetracyclines, TIMP-1 overexpression |
Mmp9 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mmp9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Yong HY, et al. (2011). Matrix metalloproteinase-9 in neurodegeneration. Brain Res Bull. 85(1-2):21-31. PMID:21376811
[2] Rosenberg GA. (2009). Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 8(2):205-216. PMID:19161908
[3] Van Den Steen PE, et al. (2008). Matrix metalloproteinases, gelatinase B and MMP-9 in neurodegenerative diseases. Curr Alzheimer Res. 5(2):158-169. PMID:18393828
[4] Lorenzl S, et al. (2006). Matrix metalloproteinases are elevated in CSF of various neurodegenerative disorders. J Neurol Sci. 244(1-2):83-86. PMID:16603193
[5] Brkic M, et al. (2015). Matrix metalloproteinase-9 deficiency leads to motor neuron vulnerability. Neurobiol Dis. 81:154-161. PMID:25616470